{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,15]],"date-time":"2026-06-15T04:11:08Z","timestamp":1781496668061,"version":"3.54.1"},"reference-count":29,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2019,9,1]],"date-time":"2019-09-01T00:00:00Z","timestamp":1567296000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,9,1]],"date-time":"2019-09-01T00:00:00Z","timestamp":1567296000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100004319","name":"Pfizer","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004319","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004334","name":"Merck","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004334","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Progress in Cardiovascular Diseases"],"published-print":{"date-parts":[[2019,9]]},"DOI":"10.1016\/j.pcad.2019.10.005","type":"journal-article","created":{"date-parts":[[2019,10,26]],"date-time":"2019-10-26T17:34:09Z","timestamp":1572111249000},"page":"390-394","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":14,"title":["New insights into managing symptoms during statin therapy"],"prefix":"10.1016","volume":"62","author":[{"given":"Jennifer G.","family":"Robinson","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"8","key":"10.1016\/j.pcad.2019.10.005_bb0005","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2018.5554","volume":"1","author":"Khunti","year":"2018","journal-title":"JAMA Network Open"},{"issue":"8","key":"10.1016\/j.pcad.2019.10.005_bb0010","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.117.005658","article-title":"Utilization of statins beyond the initial period after stroke and 1-year risk of recurrent stroke","volume":"6","author":"Lee","year":"2017","journal-title":"J Am Heart Assoc"},{"key":"10.1016\/j.pcad.2019.10.005_bb0015","doi-asserted-by":"crossref","first-page":"221","DOI":"10.7326\/M16-0838","article-title":"Continued statin prescriptions after adverse reactions and patient outcomes: a cohort study","volume":"167","author":"Zhang","year":"2017","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.pcad.2019.10.005_bb0020","unstructured":"Stroes ES, Thompson PD, Corsini A, et al. Statin-associated muscle symptoms: impact on statin therapy\u2014European Atherosclerosis Society Consensus Panel Statement on Assessment, Aetiology and Management. Vol 362015."},{"key":"10.1016\/j.pcad.2019.10.005_bb0025","doi-asserted-by":"crossref","first-page":"S58","DOI":"10.1016\/j.jacl.2014.03.004","article-title":"An assessment by the Statin Muscle Safety Task Force: 2014 update","volume":"8","author":"Rosenson","year":"2014","journal-title":"J Clin Lipidol"},{"issue":"7, Supplement","key":"10.1016\/j.pcad.2019.10.005_bb0030","first-page":"S35","article-title":"Diagnosis, prevention, and management of statin adverse effects and intolerance: Canadian Consensus Working Group update (2016)","volume":"32","author":"Mancini","year":"2016","journal-title":"Can J Cardiol"},{"key":"10.1016\/j.pcad.2019.10.005_bb0035","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1007\/s10557-005-5686-z","article-title":"Mild to moderate muscular symptoms with high-dosage statin therapy in hyperlipidemic patients\u2014the PRIMO study","volume":"19","author":"Bruckert","year":"2005","journal-title":"Cardiovasc Drugs Ther"},{"issue":"3","key":"10.1016\/j.pcad.2019.10.005_bb0040","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1016\/j.jacl.2012.03.003","article-title":"Understanding Statin Use in America and Gaps in Patient Education (USAGE): an internet-based survey of 10,138 current and former statin users","volume":"6","author":"Cohen","year":"2012","journal-title":"J Clin Lipidol"},{"key":"10.1016\/j.pcad.2019.10.005_bb0045","series-title":"Insights from the PALM (Patient and Provider Assessment of Lipid Management) registry","first-page":"e004249","article-title":"Prevalence and management of symptoms associated with statin therapy in community practice","volume":"11(3)","author":"Navar","year":"2018"},{"issue":"10059","key":"10.1016\/j.pcad.2019.10.005_bb0050","doi-asserted-by":"crossref","first-page":"2532","DOI":"10.1016\/S0140-6736(16)31357-5","article-title":"Interpretation of the evidence for the efficacy and safety of statin therapy","volume":"388","author":"Collins","year":"2016","journal-title":"The Lancet"},{"issue":"25, Part B","key":"10.1016\/j.pcad.2019.10.005_bb0055","doi-asserted-by":"crossref","first-page":"2889","DOI":"10.1016\/j.jacc.2013.11.002","article-title":"2013 ACC\/AHA guideline on the treatment of blood cholesterol to reduce atherosclerotic cardiovascular risk in adults: a report of the American College of Cardiology\/American Heart Association Task Force on Practice Guidelines","volume":"63","author":"Stone","year":"2014","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.pcad.2019.10.005_bb0060","doi-asserted-by":"crossref","first-page":"1670","DOI":"10.1016\/S0140-6736(10)61350-5","article-title":"Efficacy and safety of more intensive lowering of LDL cholesterol: a meta-analysis of data from 170,000 participants in 26 randomised trials","volume":"376","year":"2010","journal-title":"Lancet."},{"issue":"suppl 2","key":"10.1016\/j.pcad.2019.10.005_bb0065","first-page":"S1","article-title":"2013 ACC\/AHA guideline on the treatment of blood cholesterol to reduce atherosclerotic cardiovascular risk in adults","volume":"129","author":"Stone","year":"2014","journal-title":"Circulation."},{"key":"10.1016\/j.pcad.2019.10.005_bb0070","doi-asserted-by":"crossref","first-page":"2473","DOI":"10.1016\/S0140-6736(17)31075-9","volume":"389","author":"Gupta","year":"2017","journal-title":"Lancet."},{"issue":"6","key":"10.1016\/j.pcad.2019.10.005_bb0075","doi-asserted-by":"crossref","first-page":"758","DOI":"10.1016\/j.jacl.2015.08.006","article-title":"Efficacy and safety of alirocumab vs ezetimibe in statin-intolerant patients, with a statin rechallenge arm: the ODYSSEY ALTERNATIVE randomized trial","volume":"9","author":"Moriarty","year":"2015","journal-title":"J Clin Lipidol"},{"key":"10.1016\/j.pcad.2019.10.005_bb0080","doi-asserted-by":"crossref","first-page":"1580","DOI":"10.1001\/jama.2016.3608","article-title":"Efficacy and tolerability of evolocumab vs ezetimibe in patients with muscle-related statin intolerance: the gauss-3 randomized clinical trial","volume":"315","author":"Nissen","year":"2016","journal-title":"JAMA."},{"issue":"7","key":"10.1016\/j.pcad.2019.10.005_bb0085","doi-asserted-by":"crossref","first-page":"526","DOI":"10.7326\/0003-4819-158-7-201304020-00004","article-title":"Discontinuation of statins in routine care settings: a cohort study","volume":"158","author":"Zhang","year":"2013","journal-title":"Ann Intern Med"},{"issue":"10","key":"10.1016\/j.pcad.2019.10.005_bb0090","article-title":"Statin discontinuation, reinitiation, and persistence patterns among medicare beneficiaries after myocardial infarction","volume":"10","author":"Booth","year":"2017","journal-title":"A Cohort Study"},{"issue":"6359","key":"10.1016\/j.pcad.2019.10.005_bb0095","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1126\/science.aan1221","article-title":"Interactions between brain and spinal cord mediate value effects in nocebo hyperalgesia","volume":"358","author":"Tinnermann","year":"2017","journal-title":"Science."},{"issue":"11","key":"10.1016\/j.pcad.2019.10.005_bb0100","doi-asserted-by":"crossref","first-page":"1321","DOI":"10.1001\/jamaneurol.2018.2017","article-title":"Placebo effects on the neurologic pain signature: a meta-analysis of individual participant functional magnetic resonance imaging data","volume":"75","author":"Zunhammer","year":"2018","journal-title":"JAMA Neurol"},{"key":"10.1016\/j.pcad.2019.10.005_bb0105","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1007\/s11606-018-4540-5","article-title":"Eliciting the patient's agenda- secondary analysis of recorded clinical encounters","volume":"34","author":"Singh Ospina","year":"2019","journal-title":"J Gen Intern Med"},{"issue":"8","key":"10.1016\/j.pcad.2019.10.005_bb0110","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1001\/jamaneurol.2018.1743","article-title":"Five questions that every patient has but never asks","volume":"75","author":"Whyte","year":"2018","journal-title":"JAMA Neurol"},{"key":"10.1016\/j.pcad.2019.10.005_bb0115","doi-asserted-by":"crossref","first-page":"e253","DOI":"10.2196\/jmir.9364","article-title":"Relationship between internet health information and patient compliance based on trust: empirical study","volume":"20","author":"Lu","year":"2018","journal-title":"J Med Internet Res"},{"issue":"11","key":"10.1016\/j.pcad.2019.10.005_bb0120","doi-asserted-by":"crossref","first-page":"1309","DOI":"10.1001\/jamaneurol.2018.1752","article-title":"Modulation of nociception in multiple brain systems\u2014the strain in pain","volume":"75","author":"Spiegel","year":"2018","journal-title":"JAMA Neurol"},{"key":"10.1016\/j.pcad.2019.10.005_bb0125","article-title":"A three-talk model for shared decision making: multistage consultation process","volume":"359","author":"Elwyn","year":"2017","journal-title":"BMJ."},{"issue":"8","key":"10.1016\/j.pcad.2019.10.005_bb0130","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1001\/jamacardio.2018.1511","article-title":"Association of patient perceptions of cardiovascular risk and beliefs on statin drugs with racial differences in statin use: insights from the patient and provider assessment of lipid management registry","volume":"3","author":"Nanna","year":"2018","journal-title":"JAMA Cardiol"},{"key":"10.1016\/j.pcad.2019.10.005_bb0135","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1586\/14779072.4.4.461","article-title":"Combination therapy with ezetimibe and simvastatin to acheive aggressive LDL reduction","volume":"4","author":"Robinson","year":"2006","journal-title":"Expert Rev Cardiovasc Ther"},{"key":"10.1016\/j.pcad.2019.10.005_bb0140","doi-asserted-by":"crossref","first-page":"2387","DOI":"10.1056\/NEJMoa1410489","article-title":"Ezetimibe added to statin therapy after acute coronary syndromes","volume":"372","author":"Cannon","year":"2015","journal-title":"N Engl J Med"},{"key":"10.1016\/j.pcad.2019.10.005_bb0145","doi-asserted-by":"crossref","first-page":"1747","DOI":"10.1016\/j.amjcard.2008.02.061","article-title":"Efficacy of rosuvastatin (5 mg and 10 mg) twice a week in patients intolerant to daily statins","volume":"101","author":"Gadarla","year":"2008","journal-title":"Am J Cardiol"}],"container-title":["Progress in Cardiovascular Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0033062019301306?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0033062019301306?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,22]],"date-time":"2025-09-22T00:15:59Z","timestamp":1758500159000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0033062019301306"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,9]]},"references-count":29,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2019,9]]}},"alternative-id":["S0033062019301306"],"URL":"https:\/\/doi.org\/10.1016\/j.pcad.2019.10.005","relation":{},"ISSN":["0033-0620"],"issn-type":[{"value":"0033-0620","type":"print"}],"subject":[],"published":{"date-parts":[[2019,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"New insights into managing symptoms during statin therapy","name":"articletitle","label":"Article Title"},{"value":"Progress in Cardiovascular Diseases","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.pcad.2019.10.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}